1 / 4

Plasmapheresis Market Is Worth USD 1

The global plasmapheresis market will grow at a CAGR of 8.3% during the forecast period to reach USD 1,285.3 million by 2022, according to this latest publication from Meticulous Researchu00ae. The global plasmapheresis market is driven by increasing demand for source plasma from biopharmaceutical companies, increasing the incidence of autoimmune diseases, and favorable reimbursement for therapeutic plasmapheresis procedure. However, the high cost of plasmapheresis devices & procedures and lack of awareness about apheresis collection among the population in emerging countries is expected to hamper

amey3
Download Presentation

Plasmapheresis Market Is Worth USD 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Plasmapheresis Market Is Worth USD 1,285.3 Million By 2022 The global plasmapheresis market will grow at a CAGR of 8.3% during the forecast period to reach USD 1,285.3 million by 2022, according to this latest publication from Meticulous Research®. The global plasmapheresis market is driven by increasing demand for source plasma from biopharmaceutical companies, increasing the incidence of autoimmune diseases, and favorable reimbursement for therapeutic plasmapheresis procedure. However, the high cost of plasmapheresis devices & procedures and lack of awareness about apheresis collection among the population in emerging countries is expected to hamper the growth of plasmapheresis market during the forecast period. Market Segmentation Global plasmapheresis market is segmented by product type (instrument and disposables), by technology (membrane filtration and centrifugation), by applications (therapeutic plasmapheresis and source plasma collection), by end user (biopharmaceutical companies, hospitals & clinics, and others), and by geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa). Source plasma collection/donor plasmapheresis segment dominates the global plasmapheresis market and is also expected to increase significantly in the next 5-10 years. The large share of this segment is mainly attributed to increasing demand of source plasma from plasma fractionation industry and rising demand for plasma for transfusion in a patient with various diseases. Geographic Overview Geographically, the global plasmapheresis market is segmented into five major regions, namely North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. These regions are further analyzed at a country level with the detailed qualitative and quantitative analysis. North America accounted for the major share in the global plasmapheresis market in 2016, followed by Europe, and Asia-Pacific region. The major share of the North American region is mainly attributed to the higher adoption of plasmapheresis for source plasma collection in the U.S. & Canada, increasing incidence of autoimmune disorders, well-established healthcare system, and favorable reimbursement in the U.S. for TPE procedures performed in hospitals. However, Asian countries are slated to register the fastest growth during the forecast period, owing to the rising healthcare spending, rising living standards, increasing awareness about plasmapheresis procedure, and growing plasma fractionation industry. Key players

  2. The global plasmapheresis market is oligopolies with top three players accounting for major share of the market in 2016. The major players providing plasmapheresis instrument and disposables in the global plasmapheresis market are B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), Baxter International Inc. (U.S.), Terumo Corporation (Japan), Kawasumi Laboratories Inc. (Japan), Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Kaneka Corporation (Japan), Infomed SA (Switzerland), and Shanghai Dahua Medical Apparatus Co., Ltd. (China). Scope of the Report: Plasma Fractionation Market, by Product Immunoglobulins Intravenous Immunoglobulins (IVIg) Subcutaneous Immunoglobulins (SCIg) Intramuscular Immunoglobulins (IMIg) Coagulation Factors Albumin Protease Inhibitors Other Products Note: Other plasma-derived products include fibrin, sealant, and plasma Plasma Fractionation Market, by Application Immunology Hematology Neurology Critical Care Hematology-oncology Rheumatology & Orthopedics Other Applications Note: Other applications include the management of respiratory diseases and wound healing. Plasma Fractionation Market, by End User Hospitals & Clinics

  3. Clinical Research Laboratories Academic & Research Institutes Plasma Fractionation Market, by Geography North America U.S. Canada Europe Germany France U.K. Italy Spain Rest of Europe (RoE) Asia-Pacific China Japan India Australia Indonesia Vietnam Thailand Malaysia Rest of Asia-Pacific (RoAPAC) Latin America Brazil Mexico Columbia Peru Rest of Latin America (RoLATM) Middle East & Africa

  4. South Africa Rest of Middle East & Africa Download Sample Report -https://www.meticulousresearch.com/product/plasma-fractionation- market-5117?utm_source=PR&utm_medium=BLOG&utm_campaign=Product&utm_content=23-11- 2022

More Related